Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-10-022394
Filing Date
2010-03-09
Accepted
2010-03-09 11:58:09
Documents
12
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K f55133e10vk.htm 10-K 1654697
2 EX-10.55 f55133exv10w55.htm EX-10.55 351882
3 EX-10.56 f55133exv10w56.htm EX-10.56 229900
4 EX-21.1 f55133exv21w1.htm EX-21.1 3547
5 EX-23.1 f55133exv23w1.htm EX-23.1 3853
6 EX-31.1 f55133exv31w1.htm EX-31.1 8839
7 EX-31.2 f55133exv31w2.htm EX-31.2 8805
8 EX-32.1 f55133exv32w1.htm EX-32.1 5988
9 GRAPHIC f55133f5513303.gif GRAPHIC 13776
10 GRAPHIC f55133f5513304.gif GRAPHIC 17792
11 GRAPHIC f55133f5513305.gif GRAPHIC 4867
12 GRAPHIC f55133f5513306.gif GRAPHIC 12359
  Complete submission text file 0000950123-10-022394.txt   2336747
Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043 650.944.7000
Alexza Pharmaceuticals Inc. (Filer) CIK: 0001344413 (see all company filings)

EIN.: 770567768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51820 | Film No.: 10665978
SIC: 2834 Pharmaceutical Preparations